《右美托咪定后处理通过调控lncRNA H19和m6A修饰减轻衰老心肌细胞缺氧/复氧损伤》勘误
Corrigendum to "Dexmedetomidine Postconditioning Alleviates Hypoxia/Reoxygenation Injury in Senescent Myocardial Cells by Regulating lncRNA H19 and m6A Modification".
作者信息
Zhang Xuan, Fu Qiang, Xu Longhe, Yang Yitian, Zhao Weixing, Zhang Yunliang, Mi Weidong, Li Hao
机构信息
Anesthesia and Operation Centre, Chinese PLA General Hospital, Beijing 100853, China.
Department of Anesthesiology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
出版信息
Oxid Med Cell Longev. 2020 Aug 24;2020:7059751. doi: 10.1155/2020/7059751. eCollection 2020.
Abstract
[This corrects the article DOI: 10.1155/2020/9250512.].
摘要
[本文更正了文章的数字对象标识符：10.1155/2020/9250512。]
相似文献
1
Corrigendum to "Dexmedetomidine Postconditioning Alleviates Hypoxia/Reoxygenation Injury in Senescent Myocardial Cells by Regulating lncRNA H19 and m6A Modification".《右美托咪定后处理通过调控lncRNA H19和m6A修饰减轻衰老心肌细胞缺氧/复氧损伤》勘误
Oxid Med Cell Longev. 2020 Aug 24;2020:7059751. doi: 10.1155/2020/7059751. eCollection 2020.
2
The lncRNA, H19 Mediates the Protective Effect of Hypoxia Postconditioning Against Hypoxia-Reoxygenation Injury to Senescent Cardiomyocytes by Targeting microRNA-29b-3p.长链非编码 RNA H19 通过靶向 microRNA-29b-3p 介导低氧后处理对衰老心肌细胞缺氧/复氧损伤的保护作用。
Shock. 2019 Aug;52(2):249-256. doi: 10.1097/SHK.0000000000001213.
3
ALKBH5 ALLEVIATES HYPOXIA POSTCONDITIONING INJURY IN d -GALACTOSE-INDUCED SENESCENT CARDIOMYOCYTES BY REGULATING STAT3.ALKBH5 通过调控 STAT3 减轻 d-半乳糖诱导的衰老心肌细胞缺氧后处理损伤。
Shock. 2023 Jan 1;59(1):91-98. doi: 10.1097/SHK.0000000000002031. Epub 2023 Jan 8.
4
Sevoflurane postconditioning alleviates hypoxia-reoxygenation injury of cardiomyocytes by promoting mitochondrial autophagy through the HIF-1/BNIP3 signaling pathway.七氟醚后处理通过HIF-1/BNIP3信号通路促进线粒体自噬，减轻心肌细胞缺氧复氧损伤。
PeerJ. 2019 Jun 24;7:e7165. doi: 10.7717/peerj.7165. eCollection 2019.
5
Corrigendum to "Vanillic Acid Alleviates Acute Myocardial Hypoxia/Reoxygenation Injury by Inhibiting Oxidative Stress".《香草酸通过抑制氧化应激减轻急性心肌缺氧/复氧损伤》勘误
Oxid Med Cell Longev. 2022 Jan 27;2022:9891489. doi: 10.1155/2022/9891489. eCollection 2022.
6
Dexmedetomidine attenuates hypoxia/reoxygenation injury in primary neonatal rat cardiomyocytes.右美托咪定减轻原代新生大鼠心肌细胞的缺氧/复氧损伤。
Exp Ther Med. 2017 Jul;14(1):689-695. doi: 10.3892/etm.2017.4537. Epub 2017 Jun 1.
7
[Role of the lncRNA H19/ microRNA-203a/PTEN axis in ischemia-reperfusion injury of mouse GC-1 cells and its mechanism].[长链非编码RNA H19/微小RNA-203a/PTEN轴在小鼠GC-1细胞缺血再灌注损伤中的作用及其机制]
Zhonghua Nan Ke Xue. 2020 Jun;26(6):499-504.
8
Corrigendum: Sevoflurane Alleviates Myocardial Ischemia Reperfusion Injury by Inhibiting P2X7-NLRP3 Mediated Pyroptosis.勘误：七氟醚通过抑制P2X7-NLRP3介导的细胞焦亡减轻心肌缺血再灌注损伤。
Front Mol Biosci. 2022 Apr 13;9:901322. doi: 10.3389/fmolb.2022.901322. eCollection 2022.
9
Urocortin I Protects against Myocardial Ischemia/Reperfusion Injury by Sustaining Respiratory Function and Cardiolipin Content via Mitochondrial ATP-Sensitive Potassium Channel Opening.尿皮质素 I 通过开放线粒体三磷酸腺苷敏感性钾通道来维持呼吸功能和心磷脂含量，从而防止心肌缺血/再灌注损伤。
Oxid Med Cell Longev. 2022 Mar 29;2022:7929784. doi: 10.1155/2022/7929784. eCollection 2022.
10
Efficacy and mechanism of hypoxic postconditioning in salvage of ex vivo human rectus abdominis muscle from hypoxia/reoxygenation injury.缺氧后处理对体外培养的人腹直肌缺氧/复氧损伤的挽救作用及机制
Eur J Pharmacol. 2012 Jul 5;686(1-3):90-6. doi: 10.1016/j.ejphar.2012.04.045. Epub 2012 May 2.
引用本文的文献
1
Epitranscriptomic Regulations in the Heart.心脏中的转录后调控
Physiol Res. 2024 Apr 18;73(Suppl 1):S185-S198. doi: 10.33549/physiolres.935265.
2
LncRNA H19: A Novel Biomarker in Cardiovascular Disease.长链非编码RNA H19：心血管疾病中的一种新型生物标志物。
Acta Cardiol Sin. 2024 Mar;40(2):172-181. doi: 10.6515/ACS.202403_40(2).20230925A.
3
m6A epitranscriptomic and epigenetic crosstalk in cardiac fibrosis.m6A 转录组和表观遗传学在心脏纤维化中的相互作用。
Mol Ther. 2024 Apr 3;32(4):878-889. doi: 10.1016/j.ymthe.2024.01.037. Epub 2024 Feb 3.
4
mA RNA methylation: A dynamic regulator of cardiac muscle and extracellular matrix.mRNA甲基化：心肌和细胞外基质的动态调节因子。
Curr Opin Physiol. 2022 Aug;28. doi: 10.1016/j.cophys.2022.100561. Epub 2022 Jun 3.
5
Role of N6-methyladenosine Modification in Cardiac Remodeling.N6-甲基腺苷修饰在心脏重塑中的作用。
Front Cardiovasc Med. 2022 Feb 10;9:774627. doi: 10.3389/fcvm.2022.774627. eCollection 2022.
6
Role of N-Methyladenosine RNA Modification in Cardiovascular Disease.N-甲基腺苷RNA修饰在心血管疾病中的作用
Front Cardiovasc Med. 2021 May 7;8:659628. doi: 10.3389/fcvm.2021.659628. eCollection 2021.
7
The role of MA modification in the regulation of tumor-related lncRNAs.MA修饰在肿瘤相关长链非编码RNA调控中的作用。
Mol Ther Nucleic Acids. 2021 Apr 9;24:768-779. doi: 10.1016/j.omtn.2021.04.002. eCollection 2021 Jun 4.
8
N-methyladenosine (mA) methylation in ischemia-reperfusion injury.缺血再灌注损伤中的 N-甲基腺苷（m6A）甲基化。
Cell Death Dis. 2020 Jun 24;11(6):478. doi: 10.1038/s41419-020-2686-7.
Zotero 插件